Table 1.
Demographics of COVID-19 Inpatients at NYU Langone Hospitals
| Variable | Grouped by Hospital | |||
|---|---|---|---|---|
| Overall | NYU Langone Brooklyn | NYU Langone Long Island | Tisch Hospital | |
| Total | 7,209 | 2,163 | 2,429 | 2,617 |
| Sex, no. (%) | ||||
| Female | 3,007 (41.7) | 893 (41.3) | 1,046 (43.1) | 1,068 (40.8) |
| Male | 4,202 (58.3) | 1,270 (58.7) | 1,383 (56.9) | 1,549 (59.2) |
| Age, median y (range) | 65.0 (20.0–94.0) | 65.0 (20.0–94.0) | 65.0 (20.0–94.0) | 65.0 (20.0–94.0) |
| Deceased, no. (%) | 1,430 (19.8) | 565 (26.1) | 472 (19.4) | 393 (15.0) |
| Length of stay, median d (IQR) | 5.9 (3.2–11.3) | 5.2 (2.9–10.1) | 6.5 (3.9–12.0) | 6.0 (3.1–11.9) |
| Time period, no. (%) | ||||
| First wave | 4,309 (59.8) | 1,272 (58.8) | 1,378 (56.7) | 1,659 (63.4) |
| Later pandemic | 2,900 (40.2) | 891 (41.2) | 1,051 (43.3) | 958 (36.6) |
| Smoking status, no. (%) | ||||
| Current smoker | 235 (3.3) | 69 (3.2) | 54 (2.2) | 112 (4.3) |
| Former smoker | 1,525 (21.2) | 364 (16.8) | 548 (22.6) | 613 (23.4) |
| Never smoker | 3,779 (52.4) | 1,006 (46.5) | 1,217 (50.1) | 1,556 (59.5) |
| Unknown | 1,670 (23.2) | 724 (33.5) | 610 (25.1) | 336 (12.8) |
| Asthma, no. (%) | 953 (13.2) | 278 (12.9) | 303 (12.5) | 372 (14.2) |
| Bronchiectasis, no. (%) | 127 (1.8) | 31 (1.4) | 31 (1.3) | 65 (2.5) |
| Cystic fibrosis, no. (%) | 2 (0.0) | 2 (0.1) | ||
| COPD, no. (%) | 735 (10.2) | 236 (10.9) | 246 (10.1) | 253 (9.7) |
| ILD, no. (%) | 239 (3.3) | 77 (3.6) | 75 (3.1) | 87 (3.3) |
| Maximum oxygen requirements <48 h of admission, no. (%) | ||||
| Ventilator | 477 (6.6) | 154 (7.1) | 147 (6.1) | 176 (6.7) |
| High-flow nasal cannula | 722 (10.0) | 176 (8.1) | 245 (10.1) | 301 (11.5) |
| Nasal cannula | 3,973 (55.1) | 1,151 (53.2) | 1,447 (59.6) | 1,375 (52.5) |
| Room air | 2,037 (28.3) | 682 (31.5) | 590 (24.3) | 765 (29.2) |
| Maximum oxygen requirements >48 h after admission, no. (%) | ||||
| Ventilator | 1,168 (16.2) | 380 (17.6) | 380 (15.6) | 408 (15.6) |
| High-flow nasal cannula | 986 (13.7) | 226 (10.4) | 396 (16.3) | 364 (13.9) |
| Nasal cannula | 3,604 (50.0) | 1,083 (50.1) | 1,247 (51.3) | 1,274 (48.7) |
| Room air | 1,451 (20.1) | 474 (21.9) | 406 (16.7) | 571 (21.8) |
| Peak WHO score in the first 48 h of admission, no. (%) | ||||
| 4.0 | 1,065 (25.7) | 289 (24.7) | 359 (24.4) | 417 (27.7) |
| 5.0 | 1,667 (40.2) | 500 (42.8) | 596 (40.5) | 571 (38.0) |
| 6.0 | 611 (14.7) | 154 (13.2) | 240 (16.3) | 217 (14.4) |
| 7.0 | 113 (2.7) | 37 (3.2) | 29 (2.0) | 47 (3.1) |
| 8.0 | 441 (10.6) | 104 (8.9) | 165 (11.2) | 172 (11.4) |
| 9.0 | 75 (1.8) | 20 (1.7) | 24 (1.6) | 31 (2.1) |
| 10.0 | 171 (4.1) | 64 (5.5) | 59 (4.0) | 48 (3.2) |
| Peak WHO score beyond the first 48 h of admission, no. (%) | ||||
| 4.0 | 1,037 (18.0) | 301 (17.7) | 321 (16.0) | 415 (20.1) |
| 5.0 | 2,582 (44.7) | 754 (44.4) | 905 (45.1) | 923 (44.7) |
| 6.0 | 738 (12.8) | 145 (8.5) | 312 (15.6) | 281 (13.6) |
| 7.0 | 42 (0.7) | 15 (0.9) | 15 (0.7) | 12 (0.6) |
| 8.0 | 207 (3.6) | 52 (3.1) | 56 (2.8) | 99 (4.8) |
| 9.0 | 170 (2.9) | 30 (1.8) | 57 (2.8) | 83 (4.0) |
| 10.0 | 995 (17.2) | 401 (23.6) | 340 (16.9) | 254 (12.3) |
| Ventilator days, median (IQR) | 10.0 (4.0–19.0) | 6.0 (2.0–13.0) | 10.0 (5.0–19.0) | 14.0 (6.0–23.0) |
| Central line placed, no. (%) | 998 (13.8) | 321 (14.8) | 371 (15.3) | 306 (11.7) |
Note. IQR, interquartile range; COPD, chronic obstructive pulmonary disease; ILI, influenza-like illness; WHO, World Health Organization.